{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T06:03:32Z","timestamp":1704434612678},"reference-count":57,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2014.00085","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T09:24:29Z","timestamp":1401960269000},"source":"Crossref","is-referenced-by-count":7,"title":["Behavioral and Neurophysiological Effects of Transdermal Rotigotine in Atypical Parkinsonism"],"prefix":"10.3389","volume":"5","author":[{"given":"Davide Vito","family":"Moretti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliano","family":"Binetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orazio","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Battista","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.10459","article-title":"Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders","volume":"18","author":"Litvan","year":"2003","journal-title":"Mov Disord"},{"issue":"Pt 6","key":"B2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u00e2\u20ac\u2122s syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","article-title":"The natural history of multiple system atrophy: a prospective European cohort study","volume":"12","author":"Wenning","year":"2013","journal-title":"Lancet Neurol"},{"issue":"9","key":"B5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/mds.25509","article-title":"\u00e2\u20ac\u02dcAtypical\u00e2\u20ac\u2122 parkinsonism: new genetic disorders presenting with features of PSP, MSA or CBD","volume":"28","author":"Stamelou","year":"2013","journal-title":"Mov Disord"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/jnnp.2004.052332","article-title":"The role of levodopa in the management of dementia with Lewy bodies","volume":"76","author":"Molloy","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/jnnp.70.5.662","article-title":"Clinical phenotype in patients with \u00ce\u00b1-synuclein Parkinson\u00e2\u20ac\u2122s disease living in Greece in comparison with patients with sporadic Parkinson\u00e2\u20ac\u2122s disease","volume":"70","author":"Papapetropoulos","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1212\/01.WNL.0000130194.84594.96","article-title":"L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia","volume":"63","author":"Bonelli","year":"2004","journal-title":"Neurology"},{"issue":"15","key":"B9","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/mds.21578","article-title":"Levodopa responsiveness in disorders with parkinsonism: a review of the literature","volume":"22","author":"Constantinescu","year":"2007","journal-title":"Mov Disord"},{"issue":"12","key":"B10","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2165\/00023210-200721120-00007","article-title":"Rotigotine transdermal patch: a review of its use in the management of Parkinson\u00e2\u20ac\u2122s disease","volume":"21","author":"Baldwin","year":"2007","journal-title":"CNS Drugs"},{"key":"B11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson\u00e2\u20ac\u2122s disease: a double-blind, double-dummy, randomised controlled trial","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol"},{"issue":"8","key":"B12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2165\/11206750-000000000-00000","article-title":"Rotigotine transdermal patch: a review of its use in the treatment of Parkinson\u00e2\u20ac\u2122s disease","volume":"25","author":"Sanford","year":"2011","journal-title":"CNS Drugs"},{"issue":"7","key":"B13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00702-012-0925-5","article-title":"Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson\u00e2\u20ac\u2122s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER","volume":"120","author":"LeWitt","year":"2013","journal-title":"J Neural Transm"},{"issue":"7","key":"B14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.parkreldis.2013.02.018","article-title":"Rotigotine and specific non-motor symptoms of Parkinson\u00e2\u20ac\u2122s disease: post hoc analysis of RECOVER","volume":"19","author":"Ray Chaudhuri","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"B15","doi-asserted-by":"publisher","first-page":"e69738","DOI":"10.1371\/journal.pone.0069738","article-title":"Rotigotine transdermal patch in Parkinson\u00e2\u20ac\u2122s disease: a systematic review and meta-analysis","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"B16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2165\/00002018-200932060-00004","article-title":"Behavioural adverse effects of dopaminergic treatments in Parkinson\u00e2\u20ac\u2122s disease: incidence, neurobiological basis, management and prevention","volume":"32","author":"Antonini","year":"2009","journal-title":"Drug Saf"},{"issue":"Suppl 1","key":"B17","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/S1353-8020(11)70026-8","article-title":"Impulse control disorders in Parkinson\u00e2\u20ac\u2122s disease","volume":"18","author":"Vilas","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"B18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.parkreldis.2010.06.009","article-title":"High compliance with rotigotine transdermal patch in the treatment of idiopathic Parkinson\u00e2\u20ac\u2122s disease","volume":"16","author":"Schnitzler","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Rotigotine effects on early morning motor function and sleep in Parkinson\u00e2\u20ac\u2122s disease: a double-blind, randomized, placebo-controlled study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord"},{"key":"B20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/jnnp.58.2.160","article-title":"Clinicopathological study of 35 cases of multiple system atrophy","volume":"58","author":"Wenning","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/mds.870120203","article-title":"Multiple system atrophy: a review of 203 pathologically proven cases","volume":"12","author":"Wenning","year":"1997","journal-title":"Mov Disord"},{"key":"B22","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/jnnp.67.5.620","article-title":"Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study","volume":"67","author":"Wenning","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.21465","article-title":"Multiple system atrophy: a primary oligodendrogliopathy","volume":"64","author":"Wenning","year":"2008","journal-title":"Ann Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/jnnp.60.6.615","article-title":"Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study","volume":"60","author":"Litvan","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Pt 7","key":"B27","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awq123","article-title":"Does corticobasal degeneration exist? A clinicopathological re-evaluation","volume":"133","author":"Ling","year":"2010","journal-title":"Brain"},{"issue":"5","key":"B28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/ane.12067","article-title":"Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools","volume":"127","author":"Liscic","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"B29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"issue":"5 Movement Disorders","key":"B30","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1212\/01.CON.0000436152.24038.e0","article-title":"Parkinsonian syndromes","volume":"19","author":"Williams","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"B31","first-page":"153","article-title":"Unified Parkinson\u00e2\u20ac\u2122s disease rating scale","volume-title":"Recent Developments in Parkinson\u00e2\u20ac\u2122s Disease","author":"Fahn","year":"1987"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"B33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u00e2\u20ac\u02dcMini mental state\u00e2\u20ac\u2122: a practical method for grading the cognitive state of patients for clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1391e402","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the unified multiple system atrophy rating scale (UMSARS)","volume":"19","author":"Wenning","year":"2004","journal-title":"Mov Disord"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1552e65","DOI":"10.1093\/brain\/awm032","article-title":"A clinical rating scale for progressive supranuclear palsy","volume":"130","author":"Golbe","year":"2007","journal-title":"Brain"},{"issue":"11","key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20153","article-title":"Assessment of autonomic dysfunction in Parkinson\u00e2\u20ac\u2122s disease: the SCOPA-AUT","volume":"19","author":"Visser","year":"2004","journal-title":"Mov Disord"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson\u00e2\u20ac\u2122s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"B38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fneur.2013.00054","article-title":"Assessing bradykinesia in parkinsonian disorders","volume":"4","author":"Pal","year":"2013","journal-title":"Front Neurol"},{"issue":"3","key":"B39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3233\/JAD-2008-15302","article-title":"Brain vascular damage of cholinergic pathways and EEG markers in mild cognitive impairment","volume":"15","author":"Moretti","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrneurol.2011.43","article-title":"Corticobasal degeneration: a pathologically distinct 4R tauopathy","volume":"7","author":"Kouri","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/mds.23336","article-title":"Clinical correlates of similar pathologies in parkinsonian syndromes","volume":"26","author":"Song","year":"2011","journal-title":"Mov Disord"},{"key":"B42","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/jnnp.68.4.434","article-title":"What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson\u00e2\u20ac\u2122s disease?","volume":"68","author":"Wenning","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy. An analysis of 100 cases","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain"},{"key":"B44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/WCO.0b013e3283480569","article-title":"New insights into atypical parkinsonism","volume":"24","author":"Wenning","year":"2011","journal-title":"Curr Opin Neurol"},{"issue":"Suppl 1","key":"B45","first-page":"1182","article-title":"A randomized, placebo-controlled clinical trial to assess the effects of rasagiline in patients with multiple system atrophy of the parkinsonian subtype","volume":"27","author":"Poewe","year":"2012","journal-title":"Mov Disord"},{"key":"B46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2377-12-131","article-title":"Treatment of multiple system atrophy using intravenous immunoglobulin","volume":"12","author":"Novak","year":"2012","journal-title":"BMC Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.23612","article-title":"A randomized trial of mesenchymal stem cells in multiple system atrophy","volume":"72","author":"Lee","year":"2012","journal-title":"Ann Neurol"},{"issue":"4","key":"B48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/mds.25815","article-title":"Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial","volume":"29","author":"H\u00c3\u00b6glinger","year":"2014","journal-title":"Mov Disord"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/brain\/awq115","article-title":"Rational therapeutic approaches to progressive supranuclear palsy","volume":"133","author":"Stamelou","year":"2010","journal-title":"Brain"},{"key":"B50","first-page":"954","article-title":"Loss of dopamine-D2 receptor binding sites in parkinsonian plus syndromes","volume":"39","author":"Hierholzer","year":"1998","journal-title":"J Nucl Med"},{"issue":"7","key":"B51","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.amjmed.2009.01.025","article-title":"Pharmacological management of psychosis in elderly patients with parkinsonism","volume":"122","author":"Hasnain","year":"2009","journal-title":"Am J Med"},{"issue":"1","key":"B52","first-page":"94","article-title":"Othello syndrome in patients with Parkinson\u00e2\u20ac\u2122s disease","volume":"22","author":"Georgiev","year":"2010","journal-title":"Psychiatr Danub"},{"issue":"1","key":"B53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00210-008-0341-4","article-title":"The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson\u00e2\u20ac\u2122s disease","volume":"379","author":"Scheller","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"B54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neulet.2007.12.001","article-title":"Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson\u00e2\u20ac\u2122s disease","volume":"432","author":"Scheller","year":"2008","journal-title":"Neurosci Lett"},{"issue":"1","key":"B55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson\u00e2\u20ac\u2122s disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1212\/01.wnl.0000259516.61938.bb","article-title":"SP 650 study group advanced Parkinson disease treated with rotigotine transdermal system: PREFER study","volume":"68","author":"LeWitt","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"B57","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/mds.21033","article-title":"Oscillations in the basal ganglia under normal conditions and in movement disorders","volume":"21","author":"Gatev","year":"2006","journal-title":"Mov Disord"}],"container-title":["Frontiers in Neurology"],"original-title":[],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T08:31:08Z","timestamp":1565512268000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2014.00085\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,5]]},"references-count":57,"URL":"https:\/\/doi.org\/10.3389\/fneur.2014.00085","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,5]]}}}